Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
The level of anxiety in USA now several notches higher after cats, cows and other mammals catching and many dying with highly pathogenic avian H5N1. I would suggest people read Rick Bright’s twitter feed. Some posters here may recall his support for SNG as important tool for host directed anti-viral.
https://x.com/rickabright/status/1783903851889959302?s=46&t=lUUs8mZ3DzN0LONpU_7P4w
Ceres have invested heavily in SOEC electrolysers too though that tech isn’t quite as mature. Only 1 licensing agreement for SOEC- Taiwanese company? Delta.
Big difference though in strategy. Ceres are purely a technology company and license out to manufacturers, ITM are a manufacturer.
I suspect rise is on the back of EU plan to ensure 40% of H2 equipment (electrolysers, fuel cells and everything that goes with them) are made in EU. Nel also rose well on the day but despite really positive RNS only marginal rise for ITM.
In my view this is bigger than the shell deal. JCB hygen, Weightbus all heavily invested and committed to hydrogen. Skin in the game, so to speak.
Shell on the other hand- playing all the cards, committed to no specific electrolyser technology or company and will probably make more profit if hydrogen fails to take off.
I’m surprised SP hasn’t flown with this. I think that is more to do with market sentiment than anything else. Not very forward thinking at the moment.
I think the numbers here probably give a clear path to profitability. Cash position decent. For me this makes ITM number one H2 electrolyser company.
Well done DS. Ship appears steadied. I will be looking to top up more.
Alma
https://www.ceres.tech/news/ceres-and-alma-announce-maritime-collaboration/
Https://news.cgtn.com/news/2024-04-15/Scholz-hails-Germany-China-hydrogen-technology-cooperation-1sOUBmv7M4g/p.html
No mention directly here of ceres power but Bosch, fuel cell and Chiba clearly includes Ceres. Just mood music but who knows when the Weichai Bosch and Ceres triangle will reconnect.
Volume is up too. Usually the number of trades is less than the number of comments on this board. I think this share may be unique in that regard.
I keep waiting for it to become a “meme” stock.
Joking aside, the scientific basis of this therapeutic is sound. UKHSA study adds power and credence to that.
I hope none of us really know when news is inbound. I think any substantial news has to be positive. No news though is difficult to interpret and if none forthcoming there is a likely of drift back in SP. I can’t see the UK HSA poster being worthy of a big re-rate in SP though I may be wrong.
Https://x.com/rickabright/status/1775574461233684652?s=46&t=lUUs8mZ3DzN0LONpU_7P4w
Avian flu has been around for a while and jumped numerous species but not transmitted human to human. There does seem to be a fair amount of worry about this latest development.
Pandemic preparedness vital. Synairgen needs to get over the line.
I seem to recall ITM telling us they wouldn’t be putting out RNS for smaller sales.
Having said that, this looks fairly significant. They did announce on twitter in January that they were shipping a Neptune unit to east Asia.
It does add another big name that ITMis doing business with. Totally agree with sentiment here. Onwards and upwards Dennis. Big announcements hopefully coming soon.
Re:share price
We need to remember the seismic change H2, SOFC and SOEC herald. There will be bad actors with much to lose from fossil fuel transition, both states and private individuals/companies. One only needs to look at the negative influence of fossil fuel lobbyists to get a taste of what is at stake and how far these actors may go.
It’s going to be a rocky ride. I’m not against fossil fuel companies taking a stake but beware those that are really just using « greenwash stalling » tactics.
Then of course there are the shortened, tampers and de-rampers.
Looking at ceres there has been a lot of transparency. Latest deal brings in £40+m in licence fees over 2 years. Royalties from licensing should start to flow in 2025. Only then will the business model be tested properly. Until then hold on to your seat.
Quite similar technology. Very different business models. Ceres just signed first SOEC manufacturing agreement last month with Taiwanese company. Bloom have their own manufacturing capability.
Blooms model much more capital intensive and they consequently have quite high debt. Ceres have no debt but at scale (beyond demonstrators) it is their manufacturing partners who would be closely involved in any deals.
I’m a little surprised SP hasn’t shifted with this but market seems to take little notice of future earnings potential ATM.
I saw with interest the post on twitter of the Doosan factory and its progression.
I guess if royalties and other income streams start to flow as anticipated the SP should follow.
I get the feeling there is time to see how things pan out before topping up.
FOMO was very 2021!